Tag Archives: diagnosing mesothelioma

Diagnosing Mesothelioma from Pleural Fluid: The Cell Block Technique

Turkish researchers say a method for concentrating cancer cells from the lung fluid of mesothelioma and lung cancer patients into a single “block” for examination may result in a more accurate diagnosis than traditional fluid analysis. Pleural effusion or excess lung fluid is often one of the first signs of mesothelioma. Patients may experience this fluid collection as chest pressure, pain, or inability to take a full breath. Suspected mesothelioma patients with pleural effusion will often undergo thoracentesis, a technique for removing some of the fluid for examination. In the current study, researchers compared the traditional method of analyzing cancer cells in pleural fluid with a method that involves concentrating those scattered cells into a “block” that can be cut through and examined … Continue reading Diagnosing Mesothelioma from Pleural Fluid: The Cell Block Technique »

FDG/PET Best for Mesothelioma Diagnosis and Prognosis

PET Scan

When it comes to diagnosing mesothelioma and predicting patient prognosis, Positron Emission Tomography (PET) using a radioactive tracer may be the most effective imaging modality. That’s the finding of a new study out of Japan. Mesothelioma is a fast-growing cancer that starts on the mesothelial membranes which line the chest cavity or wrap around the lungs and heart. It is caused by past exposure to asbestos, most often in an industrial setting. The greater the level of exposure, the greater the likelihood that mesothelioma will occur. Because it is highly resistant to conventional treatments, early diagnosis is critical. Unfortunately, mesothelioma can also be challenging to diagnose. If patient history and symptoms suggest mesothelioma, imaging modalities like computed tomography (CT) and X-rays can … Continue reading FDG/PET Best for Mesothelioma Diagnosis and Prognosis »

Diagnosing Mesothelioma

A panel of just three antibodies is highly sensitive at distinguishing mesothelioma from other cancers, according to a study in the February 2009 issue of Pathology. The authors of the study say that using this type of small antibody panel could help reduce the time and cost associated with diagnosing mesothelioma. Mesothelioma is among the deadliest of cancers; the average patient survives just one year after diagnosis. Making a timely and accurate diagnosis is crucial to help doctors determine a patient’s prognosis, identify the best treatment approach, and get patients compensated in legal claims related to asbestos-related mesothelioma, says Sonja Klebe, MD, PhD, a Senior Lecturer in the Department of Anatomical Pathology at Flinders Medical Centre in Adelaide, Australia. Mesothelioma is often … Continue reading Diagnosing Mesothelioma »